Abstract
Background
Sarcopenia is an age-related disease which leads to a decline in muscle mass and function and is one of the most important health issues in elderly people with a high rate and variety of adverse outcomes.
Objective
The current systematic review and meta-analysis study was carried out to estimate the overall prevalence of sarcopenia in both males and females in different regions around the world and to show the major differences in its occurrence among different populations.
Design
A systematic review and metaanalysis of studies published in PubMed (Medline) and Scopus.
Participants
Community dwelling, nursing home and hospitalized older adults aged over 60 years.
Measurements
Sarcopenia was defined by the major validated diagnostic criteria, such as the European Working Group on Sarcopenia in Older People (EWGSOP), the Asian Working Group for Sarcopenia (AWGS) and the International Working Group on Sarcopenia (IWGS). The model used was the random effect model for estimating the prevalence of sarcopenia. The sex-specific prevalence of sarcopenia as well as 95% CI (Confidence interval) were calculated using MetaXL (version 5.3). Heterogeneity assessment was carried out by subgroup analysis.
Results
We included 41 studies with a total of 34955 participants. The prevalence of sarcopenia in community-dwelling individuals in the included studies were 11% (95% CI: 8–13%) in men and 9% (95% CI: 7–11%) in women. The prevalence of sarcopenia in nursing-home individuals in the included studies were 51% (95% CI: 37–66%) in men and 31% (95% CI: 22–42%) in women and in hospitalized individuals were 23% (95%, CI: 15–30%) in men and 24% (95% CI: 14–35%) in women.
Conclusions
Despite the differences encountered between the studies, regarding diagnostic tools used to measure of muscle mass, different regions around the world and different populations and clinical settings, this systematic review revealed that a significant proportion of old people has sarcopenia (major in nursing homes), even in populations healthy in general. However, sarcopenia is caused by the aging progress, early diagnosis and individualized care, including physical activity and nutrition, can prevent some adverse outcomes in all populations.
Similar content being viewed by others
References
Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JWL. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas. 2015;82(4):418–423. doi:https://doi.org/10.1016/j.maturitas.2015.08.006
Martin FC, Schneider SM, Rolland Y, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–423. doi:https://doi.org/10.1093/ageing/afq034
Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–256. doi:https://doi.org/10.1016/j.jamda.2011.01.003
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates. Journals Gerontol — Ser A Biol Sci Med Sci. 2014;69 A(5):547–558. doi:https://doi.org/10.1093/gerona/glu010
Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK. Comparisons of Sarcopenia Defined by IWGS and EWGSOP Criteria Among Older People: Results From the I-Lan Longitudinal Aging Study. J Am Med Dir Assoc. 2013;14(7):528.e1-7. doi:https://doi.org/10.1016/j.jamda.2013.03.019
Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:https://doi.org/10.1016/j.jamda.2013.11.025
Wang H, Hai S, Cao L, Zhou J, Liu P, Dong BR. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people. BMC Geriatr. 2016;16(1):1–9. doi:https://doi.org/10.1186/s12877-016-0386-z
Rossi AP, Micciolo R, Rubele S, et al. Assessing the risk of sarcopenia in the elderly: The Mini Sarcopenia Risk Assessment (MSRA) questionnaire. J Nutr Heal Aging. 2017;21(6):743–749. doi:https://doi.org/10.1007/s12603-017-0921-4
Wang H, Hai S, Liu YY, et al. Association between depressive symptoms and sarcopenia in older Chinese community-dwelling individuals. Clin Interv Aging. 2018;Volume 13:1605–1611. doi:https://doi.org/10.2147/CIA.S173146
Silva Neto LS, Karnikowski MGO, Osório NB, et al. Association between sarcopenia and quality of life in quilombola elderly in Brazil. Int J Gen Med. 2016;9:89–97. doi:https://doi.org/10.2147/IJGM.S92404
Hai S, Wang H, Cao L, et al. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17(1):187. doi:https://doi.org/10.1186/s12877-017-0587-0
Hu X, Jiang J, Wang H, Zhang L, Dong B, Yang M. Association between sleep duration and sarcopenia among community-dwelling older adults. Med (United States). 2017;96(10):e6268. doi:https://doi.org/10.1097/MD.0000000000006268
Bahat G, Oren MM, Yilmaz O, Kiliç C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults. J Nutr Heal Aging. 2018;22(9):1–5. doi:https://doi.org/10.1007/s12603-018-1072-y
Wen X, An P, Chen WC, Lv Y, Fu Q. Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults. J Nutr Heal Aging. 2015;19(3):342–347. doi:https://doi.org/10.1007/s12603-014-0561-x
Clynes MA, Edwards MH, Buehring B, Dennison EM, Binkley N, Cooper C. Definitions of Sarcopenia: Associations with Previous Falls and Fracture in a Population Sample. Calcif Tissue Int. 2015;97(5):445–452. doi:https://doi.org/10.1007/s00223-015-0044-z
Akune T, Muraki S, Oka H, et al. Exercise habits during middle age are associated with lower prevalence of sarcopenia: The ROAD study. Osteoporos Int. 2014;25(3):1081–1088. doi:https://doi.org/10.1007/s00198-013-2550-z
Yoo J Il, Ha YC, Lee YK, Hana-Choi, Yoo MJ, Koo KH. High prevalence of sarcopenia among binge drinking elderly women: a nationwide population-based study. BMC Geriatr. 2017;17(1):114. doi:https://doi.org/10.1186/s12877-017-0507-3
Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014;14(SUPPL. 1):15–28. doi:https://doi.org/10.1111/ggi.12220
Dodds RM, Granic A, Davies K, Kirkwood TBL, Jagger C, Sayer AA. Prevalence and incidence of sarcopenia in the very old: findings from the Newcastle 85+ Study. J Cachexia Sarcopenia Muscle. 2017;8(2):229–237. doi:https://doi.org/10.1002/jcsm.12157
Yang M, Hu X, **e L, et al. Screening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF). J Am Med Dir Assoc. 2018;19(3):277.e1–277.e8. doi:https://doi.org/10.1016/j.jamda.2017.12.016
Lera L, Albala C, Sánchez H, et al. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria. J frailty aging. 2017;6(1):12–17. doi:https://doi.org/10.14283/jfa.2016.117
Gao L, Jiang J, Yang M, Hao Q, Luo L, Dong B. Prevalence of Sarcopenia and Associated Factors in Chinese Community-Dwelling Elderly: Comparison Between Rural and Urban Areas. J Am Med Dir Assoc. 2015;16(11):1003.e1–1003.e6. doi:https://doi.org/10.1016/j.jamda.2015.07.020
Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013;42(3):378–384. doi:https://doi.org/10.1093/ageing/afs197
Bahat G, Tufan A, Kilic C, Karan MA, Cruz-Jentoft AJ. Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality. Aging Male. October 2018:1–7. doi: https://doi.org/10.1080/13685538.2018.1511976
Ohara DG, Pegorari MS, Oliveira dos Santos NL, et al. Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study. J Nutr Health Aging. 2018;22(8):952–958. doi:https://doi.org/10.1007/s12603-018-1079-4
Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp Gerontol. 2015;69:103–110. doi:https://doi.org/10.1016/j.exger.2015.05.003
Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int. 2014;14(SUPPL. 1):46–51. doi:https://doi.org/10.1111/ggi.12210
Legrand D, Vaes B, Matheï C, Swine C, Degryse JM. The prevalence of sarcopenia in very old individuals according to the european consensus definition: Insights from the belfrail study. Age Ageing. 2013;42(6):727–734. doi:https://doi.org/10.1093/ageing/aft128
Zengin A, Jarjou LM, Prentice A, Cooper C, Ebeling PR, Ward KA. The prevalence of sarcopenia and relationships between muscle and bone in ageing West-African Gambian men and women. J Cachexia Sarcopenia Muscle. 2018;9(5):920–928. doi:https://doi.org/10.1002/jcsm.12341
Bianchi L, Ferrucci L, Cherubini A, et al. The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study. Journals Gerontol — Ser A Biol Sci Med Sci. 2016;71(2):259–264. doi:https://doi.org/10.1093/gerona/glv129
Beaudart C, Reginster J-Y, Slomian J, Buckinx F, Locquet M, Bruyère O. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits. J Musculoskelet Neuronal Interact. 2014;14(4):425–431. doi:https://doi.org/10.1007/s10843-015-0156-6
Hashemi R, Shafiee G, Motlagh AD, et al. Sarcopenia and its associated factors in Iranian older individuals: Results of SARIR study. Arch Gerontol Geriatr. 2016;66:18–22. doi:https://doi.org/10.1016/j.archger.2016.04.016
Villada FAP, Franco SAA, De Paz Fernández JA. Sarcopenia en personas mayores de 60 años residentes en la comunidad de una ciudad del norte de españa: Relación entre sus criterios diagnósticos y asociación con el rendimiento funcional. Nutr Hosp. 2015;31(5):2154–2160. doi:https://doi.org/10.3305/nh.2015.31.5.8002
Phillips A, Strobl R, Vogt S, Ladwig KH, Thorand B, Grill E. Sarcopenia is associated with disability status—results from the KORA-Age study. Osteoporos Int. 2017;28(7):2069–2079. doi:https://doi.org/10.1007/s00198-017-4027-y
Christensen MG, Piper KS, Dreier R, Suetta C, Andersen HE. Prevalence of sarcopenia in a Danish geriatric out-patient population. Dan Med J. 2018;65(6).
Yoo J Il, Ha YC, Kwon H Bin, Lee YK, Koo KH, Yoo MJ. High prevalence of sarcopenia in Korean patients after hip fracture: A case-control study. J Korean Med Sci. 2016;31(9):1479–1484. doi:https://doi.org/10.3346/jkms.2016.31.9.1479
Rossi AP, Fantin F, Micciolo R, et al. Identifying Sarcopenia in Acute Care Setting Patients. J Am Med Dir Assoc. 2014;15(4):303.e7–12. doi:https://doi.org/10.1016/j.jamda.2013.11.018
Bianchi L, Abete P, Bellelli G, et al. Prevalence and Clinical Correlates of Sarcopenia, Identified According to the EWGSOP Definition and Diagnostic Algorithm, in Hospitalized Older People: The GLISTEN Study. Journals Gerontol — Ser A Biol Sci Med Sci. 2017;72(11):1575–1581. doi:https://doi.org/10.1093/gerona/glw343
Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc. 2014;15(4):267–272. doi:https://doi.org/10.1016/j.jamda.2013.11.027
Buckinx F, Reginster JY, Brunois T, et al. Prevalence of sarcopenia in a population of nursing home residents according to their frailty status: Results of the SENIOR cohort. J Musculoskelet Neuronal Interact. 2017;17(3):209–217. doi:https://doi.org/10.1007/s00198-016-3520-z
Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. Journals Gerontol — Ser A Biol Sci Med Sci. 2012;67 A(1):48–55. doi:https://doi.org/10.1093/gerona/glr035
Jacobsen EL, Brovold T, Bergland A, Bye A. Prevalence of factors associated with malnutrition among acute geriatric patients in Norway: a cross-sectional study. BMJ Open. 2016;6(9):e011512. doi:https://doi.org/10.1136/bmjopen-2016-011512
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF. Sarcopenia among hospitalized patients — A cross-sectional study. Clin Nutr. 2015;34(6):1239–1244. doi:https://doi.org/10.1016/j.clnu.2014.12.015
Martone AM, Bianchi L, Abete P, et al. The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle. 2017;8(6):907–914. doi:https://doi.org/10.1002/jcsm.12224
Cerri AP, Bellelli G, Mazzone A, et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly: Prevalence and outcomes. Clin Nutr. 2015;34(4):745–751. doi:https://doi.org/10.1016/j.clnu.2014.08.015
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43(6):48–759. doi:https://doi.org/10.1093/ageing/afu115
Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: A systematic review and meta- analysis of general population studies. J Diabetes Metab Disord. 2017;16(1):21. doi:https://doi.org/10.1186/s40200-017-0302-x
Tay L, Ding YY, Leung BP, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. Age (Omaha). 2015;37(6):1–12. doi:https://doi.org/10.1007/s11357-015-9860-3
Janssen IAN, Heymsfield SB, Baumgartner RN, et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis. 2000:465–471.
Lee JSW, Auyeung T, Lau EMC, Leung P, Woo J. Associated Factors and Health Impact of Sarcopenia in Older Chinese Men and Women: A Cross-Sectional Study. 2007:404–410. doi:https://doi.org/10.1159/000107355
Chien M-Y, Huang T-Y, Wu Y-T. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc. 2008;56(9):1710–1715. doi:https://doi.org/10.1111/j.1532-5415.2008.01854.x
Shen Y, Chen J, Chen X, Hou LS, Lin X, Yang M. Prevalence and Associated Factors of Sarcopenia in Nursing Home Residents: A Systematic Review and Meta-analysis. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2018.09.012. Published January 2018.
Alfonso J Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, Stéphane M Schneider, Cornel C Sieber, Eva Topinkova, Maurits Vandewoude, Marjolein Visser, Mauro Zamboni, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2, Sarcopenia: revised European consensus on definition and diagnosis, Age and Ageing, Volume 48, Issue 1, Januaiy 2019, Pages 16–31, https://doi.org/10.1093/ageing/afy169
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest: None for all authors
Rights and permissions
About this article
Cite this article
Papadopoulou, S.K., Tsintavis, P., Potsaki, G. et al. Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis. J Nutr Health Aging 24, 83–90 (2020). https://doi.org/10.1007/s12603-019-1267-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-019-1267-x